Hydrogel drug delivery systems for minimally invasive local immunotherapy of cancer
Author:
Funder
National Institutes of Health
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference202 articles.
1. Estimation of the Percentage of US Patients with Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs;Haslam;JAMA Netw. Open,2019
2. Immune-Related Adverse Events Associated with Immune Checkpoint Blockade;Postow;N. Engl. J. Med.,2018
3. Effects of Single-Dose Interleukin-12 Exposure on Interleukin-12-Associated Toxicity and Interferon-Gamma Production;Leonard;Blood,1997
4. Tilsotolimod with Ipilimumab Drives Tumor Responses in Anti-Pd-1 Refractory Melanoma;Haymaker;Cancer Discov.,2021
5. Intralesional Sd-101 in Combination with Pembrolizumab in Anti-Pd-1 Treatment-Naïve Head and Neck Squamous Cell Carcinoma: Results from a Multicenter, Phase Ii Trial;Cohen;Clin. Cancer Res.,2022
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Chitosan/dextran-based organohydrogel delivers EZH2 inhibitor to epigenetically reprogram chemo/immuno-resistance in unresectable metastatic melanoma;Carbohydrate Polymers;2024-12
2. Injectable thermosensitive hydrogels loaded with irradiated tumor cell-derived microparticles and manganese activate anti-tumor immunity;Nano Today;2024-10
3. Biohybrid hydrogel inhibiting β-klotho/HDAC3 axis for hepatocellular carcinoma treatment;International Journal of Biological Macromolecules;2024-10
4. Bioinspired micro-nano hierarchical delivery system for sequential targeted therapy of inflammatory bowel disease;Chemical Engineering Journal;2024-10
5. Innovative hydrogel-based delivery systems for immunotherapy: A review of pre-clinical progress;Nano Research;2024-09-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3